STOCK TITAN

[EFFECT] Biodexa Pharmaceuticals Plc SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 30, 2026
Accession Number: 0001214659-26-003934
Submission Type: POS AM
CIK: 0001643918
Company Name: Biodexa Pharmaceuticals Plc
File Number: 333-281489